Neogen【NEOG】銘柄情報

Neogen Corporation (NEOG) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

9.31

( 4.26% )

買値

8.71

売値

9.58

出来高

5,065,605

8.97 日の範囲 9.33

4.5601 52 週間の範囲 11.425

時価総額

2.027B

前日終値

8.93

始値

9.17

時刻

458

9.3072

(average)

最終取引時間

財務取引量

US$ 46,394,635

VWAP

9.1588

平均取引量 (3 か月)

US$ 2,555,974

発行済株式数

217,673,041

配当利回り

PER

-3.25

1 株当たり利益 (EPS)

-2.79

歳入

870.56M

純利益

-608.84M

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to... Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.neogen.com

本社

Lansing, United States

設立

1981

Neogen Corporation is listed in the Healthcare sector of the ナスダック市場 with ticker NEOG. The last closing price for Neogen was US$8.93. Over the last year, Neogen shares have traded in a share price range of US$ 4.5601 to US$ 11.425.

Neogen currently has 217,673,041 shares in issue. The market capitalisation of Neogen is US$2.03 billion. Neogen has a price to earnings ratio (PE ratio) of -3.25.

Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm

Company expands availability of FIFRA 2(ee) recommendations to counter threat Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form SD - Specialized disclosure report

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.1	1.08577633008	9.21	9.505	8.885	1392292	9.17517828	CS
4	0.59	6.76605504587	8.72	9.505	8.5	2510304	9.03687764	CS
12	0.27	2.98672566372	9.04	10.83	8.16	2481589	9.19637715	CS
26	2.17	30.3921568627	7.14	11.425	6.89	2889248	9.46041301	CS
52	4.06	77.3333333333	5.25	11.425	4.5601	4168092	6.91046562	CS
156	-11.35	-54.9370764763	20.66	24.095	3.8701	3094778	9.8285626	CS
260	-36.35	-79.6101620675	45.66	47.8	3.8701	2615716	12.65605688	CS

NEOG - Frequently Asked Questions (FAQ)

What is the current Neogen Corporation share price?

The current share price of Neogen Corporation is US$ 9.31

How many Neogen Corporation shares are in issue?

Neogen Corporation has 217,673,041 shares in issue

What is the market cap of Neogen Corporation?

The market capitalisation of Neogen Corporation is USD 2.03B

What is the 1 year trading range for Neogen Corporation share price?

Neogen Corporation has traded in the range of US$ 4.5601 to US$ 11.425 during the past year

What is the PE ratio of Neogen Corporation?

The price to earnings ratio of Neogen Corporation is -3.25

What is the cash to sales ratio of Neogen Corporation?

The cash to sales ratio of Neogen Corporation is 2.28

What is the registered address of Neogen Corporation?

The registered address for Neogen Corporation is 620 Lesher Place, Lansing, Michigan, 48912-1595

What is the Neogen Corporation website address?

The website address for Neogen Corporation is www.neogen.com

Which industry sector does Neogen Corporation operate in?

Neogen Corporation operates in the Medical Diagnostics & Screening sector

Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World ScrewwormJune 18, 2026 8:45 AM
Business Wire Company expands availability of FIFRA 2(ee) recommendations to counter threat Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livestock producers, and horse owners with an additional option to support fly management efforts. In Texas, the Texas Department of Agriculture has approved Section 2(ee) recommendations for these products. Neogen is also making Section 2(ee) recommendations available in Florida, providing producers in both states with additional tools to incorporate into broader fly management programs. While NWS was largely eradicated from the United States decades ago, recent developments have increased industry attention on prevention, vigilance, and effective fly control programs. Whether addressing emerging concerns such as NWS or routine pest pressures, prevention and prompt wound management remain important components of herd health programs. Neogen offers a broad range of insect control solutions to help producers manage insect challenges across a variety of livestock environments. Among them, Prozap® Screw Worm and Ear Tick Aerosol can help protect wounds from flies and maggots while controlling a variety of labeled pests, including ticks, gnats, and lice. Prozap® Insectrin X Concentrate can be incorporated into broader fly management programs to help manage fly populations in and around livestock facilities. USDA officials have emphasized the importance of continued vigilance, monitoring, and information sharing as the situation evolves. Although NWS has received increased attention in recent weeks, livestock producers continue to manage a range of insect-related challenges, including horn flies, stable flies, face flies, ticks, and lice, that can affect animal health, welfare, and productivity. “Producers face insect pressure every season, making prevention and routine monitoring essential parts of herd management,” said Kirk Ramsey, DVM, MS, Professional Services Veterinarian with Neogen. “Integrated fly control programs, prompt wound management, and regular observation of animals can help producers address ongoing insect challenges while remaining prepared for emerging concerns.” Neogen encourages livestock producers to work closely with their veterinarians and animal health advisors to develop insect management programs tailored to their operations and regional needs. For more information about Neogen's livestock insect control solutions, visit: https://info.neogen.com/Prozap or contact your Neogen representative. *FIFRA refers to the Federal Insecticide, Fungicide, and Rodenticide Act. These recommendations are made as permitted under FIFRA Section 2(ee). Users must be in possession of the applicable recommendation at the time of pesticide application and comply with all product label directions and applicable state requirements. **Important Use Information The FIFRA Section 2(ee) recommendations for Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol permit certain uses that do not appear on the EPA-approved product label. This recommendation has not been submitted to or approved by the U.S. Environmental Protection Agency (EPA). Users must have the 2(ee) recommendation in their possession at the time of application and must follow all applicable directions, restrictions, and precautions on the EPA-registered product label. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers. Safe Harbor Statement This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the ability of Prozap® Screw Worm and Ear Tick Aerosol and Prozap® Insectrin X Concentrate to help ranchers, livestock producers, and horse owners fight against New World Screwworm; the ability of Prozap® Screw Worm and Ear Tick Aerosol to help protect wounds from flies and maggots while controlling a variety of labeled pests, including ticks, gnats and lice; and the ability of Prozap® Insectrin X Concentrate to be incorporated into broader control programs to help manage fly populations in and around livestock facilities. These “forward-looking statements” are management’s present expectations of future events as of the date hereof and are subject to a number of known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. These risks include, but are not limited to risks relating to the integration of the 3M Food Safety business, risks related to potential tax benefits realized through the 3M transaction, risks related to tariffs and other trade measures, risks related to our international operations and expansion into new geographic markets, risks related to identified material weaknesses in our internal control over financial reporting, risks related to promoting internal growth and identifying and integrating acquisitions, risks related to failure of our systems infrastructure and security breaches of our information systems, risks related to disruption in our manufacturing and service operations, risks related to disruption of third-party package delivery services or pricing increases, risks related to dependence on key suppliers, risks related to the use of distributors for product sales, risks related to the development of new products and technologies, risks related to our ability to maintain a positive reputation, risks related to customer loss, risks related to increased raw material costs, risks related to anti-bribery, trade control, trade sanctions, and anti-corruption laws, risks related to changes in domestic and foreign laws and regulations, risks related to tax audits and changes in tax laws in different jurisdictions, risks related to deterioration in profitability, cash flow, and asset impairments, risks related to competition, risks related to agricultural marketplace, risks related to our substantial indebtedness, risks related to the outcomes of litigation and other legal proceedings, risks related to our ability to obtain and protect intellectual property, risks related to patent infringement challenges, risks related to governmental regulation, risks related to our ability to attract and retain key personnel, risks related to product or service liability claims, risks related to changing political conditions, risks related to climate change, risks related to our inability to meet stakeholder expectations around environmental, social, and governance objectives, risks related to tax legislation, and other factors discussed under the heading “Risk Factors” contained in Item 1A of the company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on July 30, 2025, as well as any updates to those risk factors filed from time to time in the company’s Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Neogen is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20260618868773/en/ Media contact:
Lauren White
PR@neogen.com Investor Contact:
Scott Gleason
(435) 395-0254
sgleason@neogen.com
Original: Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm